N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide

C113H120N24O8 — CID 159131370

IUPACN-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide
SMILESCOc1cc(OC)cc(C(=O)NCC2CCC(c3nc(-c4cc5ccccc5[nH]4)c4c(N)nccn34)CC2)c1.COc1ccc(C(=O)NCC2CCC(c3nc(-c4cc5ccccc5[nH]4)c4c(N)nccn34)CC2)c(OC)c1.Nc1nccn2c(C3CCC(CNC(=O)C4CC4c4ccccc4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC(CNC=O)CC3)nc(-c3cc4ccccc4[nH]3)c12
InChIInChI=1S/C31H32N6O.2C30H32N6O3.C22H24N6O/c32-29-28-27(26-16-22-8-4-5-9-25(22)35-26)36-30(37(28)15-14-33-29)21-12-10-19(11-13-21)18-34-31(38)24-17-23(24)20-6-2-1-3-7-20;1-38-22-13-21(14-23(16-22)39-2)30(37)33-17-18-7-9-19(10-8-18)29-35-26(27-28(31)32-11-12-36(27)29)25-15-20-5-3-4-6-24(20)34-25;1-38-21-11-12-22(25(16-21)39-2)30(37)33-17-18-7-9-19(10-8-18)29-35-26(27-28(31)32-13-14-36(27)29)24-15-20-5-3-4-6-23(20)34-24;23-21-20-19(18-11-16-3-1-2-4-17(16)26-18)27-22(28(20)10-9-25-21)15-7-5-14(6-8-15)12-24-13-29/h1-9,14-16,19,21,23-24,35H,10-13,17-18H2,(H2,32,33)(H,34,38);2*3-6,11-16,18-19,34H,7-10,17H2,1-2H3,(H2,31,32)(H,33,37);1-4,9-11,13-15,26H,5-8,12H2,(H2,23,25)(H,24,29)
InChIKeyKGXZXWGHSFLZIG-UHFFFAOYSA-N
MW1942.36 g/mol
LogP19.49
Rot. Bonds25

About N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide

N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide (PubChem CID 159131370) has the molecular formula C113H120N24O8 and a molecular weight of 1942.36 g/mol. Its IUPAC name is N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide.

Molecular Properties

Compound NameN-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide
PubChem CID159131370
Molecular FormulaC113H120N24O8
Molecular Weight1942.36 g/mol
Exact Mass1940.97
IUPAC NameN-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide
SMILESCOc1cc(OC)cc(C(=O)NCC2CCC(c3nc(-c4cc5ccccc5[nH]4)c4c(N)nccn34)CC2)c1.COc1ccc(C(=O)NCC2CCC(c3nc(-c4cc5ccccc5[nH]4)c4c(N)nccn34)CC2)c(OC)c1.Nc1nccn2c(C3CCC(CNC(=O)C4CC4c4ccccc4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC(CNC=O)CC3)nc(-c3cc4ccccc4[nH]3)c12
InChIInChI=1S/C31H32N6O.2C30H32N6O3.C22H24N6O/c32-29-28-27(26-16-22-8-4-5-9-25(22)35-26)36-30(37(28)15-14-33-29)21-12-10-19(11-13-21)18-34-31(38)24-17-23(24)20-6-2-1-3-7-20;1-38-22-13-21(14-23(16-22)39-2)30(37)33-17-18-7-9-19(10-8-18)29-35-26(27-28(31)32-11-12-36(27)29)25-15-20-5-3-4-6-24(20)34-25;1-38-21-11-12-22(25(16-21)39-2)30(37)33-17-18-7-9-19(10-8-18)29-35-26(27-28(31)32-13-14-36(27)29)24-15-20-5-3-4-6-23(20)34-24;23-21-20-19(18-11-16-3-1-2-4-17(16)26-18)27-22(28(20)10-9-25-21)15-7-5-14(6-8-15)12-24-13-29/h1-9,14-16,19,21,23-24,35H,10-13,17-18H2,(H2,32,33)(H,34,38);2*3-6,11-16,18-19,34H,7-10,17H2,1-2H3,(H2,31,32)(H,33,37);1-4,9-11,13-15,26H,5-8,12H2,(H2,23,25)(H,24,29)
InChIKeyKGXZXWGHSFLZIG-UHFFFAOYSA-N
XLogP19.49
TPSA441.32 Ų
H-Bond Donors12
H-Bond Acceptors24
Rotatable Bonds25
Heavy Atoms145
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001942.36
LogP ≤ 519.49
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[8-[(2,4-dimethoxyphenyl)methylamino]-3-(2-oxo-1,1a,4,5,6,7,7a,7b-octahydrocyclopropa[a]indolizin-5-yl)imidazo[1,5-a]pyrazin-1-yl]-3-ethoxy-N-[5-(trifluoromethyl)pyridin-2-yl]benzamide
CID 121455427
4-[8-[(2,4-dimethoxyphenyl)methylamino]-3-(2-oxo-1,1a,4,5,6,7,7a,7b-octahydrocyclopropa[a]indolizin-5-yl)imidazo[1,5-a]pyrazin-1-yl]-3-ethoxy-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide
CID 121455449
[3-(1H-benzimidazol-2-yl)azetidin-1-yl]-[4-(2-methoxyphenyl)phenyl]methanone;[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-[4-(3,4-dimethoxyphenyl)phenyl]methanone;[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-[4-(4-fluorophenoxy)phenyl]methanone;[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-[4-[4-(trifluoromethoxy)phenyl]phenyl]methanone;[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]-(4-phenylphenyl)methanone;[3-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]-(4-phenylphenyl)methanone;4-(2,4-dimethoxyphenyl)benzaldehyde;[4-(1H-imidazol-2-yl)piperidin-1-yl]-(4-phenylphenyl)methanone
CID 173072905
[3-(1H-benzimidazol-2-yl)azetidin-1-yl]-[4-(2-methoxyphenyl)phenyl]methanone;[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-[4-(2,4-dimethoxyphenyl)phenyl]methanone;[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-[4-(3,4-dimethoxyphenyl)phenyl]methanone;[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-[4-(4-fluorophenoxy)phenyl]methanone;[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-[4-[4-(trifluoromethoxy)phenyl]phenyl]methanone;[(2S)-2-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]-(4-phenylphenyl)methanone;[3-(1H-benzimidazol-2-yl)pyrrolidin-1-yl]-(4-phenylphenyl)methanone;[4-(1H-imidazol-2-yl)piperidin-1-yl]-(4-phenylphenyl)methanone
CID 173110980
N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide
CID 16678154
N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide
CID 16679648
N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxy-N-methylbenzamide
CID 68203071
N-[[4-[8-amino-1-(2,3-dihydro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide
CID 68337869
4-[8-amino-3-[1-[4-[[5-[8-amino-1-[4-[(4-propan-2-yl-2-pyridinyl)carbamoyl]phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-but-2-ynoylpyrrolidin-3-yl]methoxy]but-2-enoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-2-methoxy-N-pyridin-2-ylbenzamide
CID 123210621
4-[8-amino-3-[4-[8-amino-3-[1-(prop-2-enoylamino)ethyl]-1-[4-(pyridin-2-ylcarbamoyl)phenyl]imidazo[1,5-a]pyrazin-7-ium-7-yl]-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-2-methoxy-N-pyridin-2-ylbenzamide
CID 124031491
N-[2-[7-[3-[(2,4-dimethoxybenzoyl)amino]-4-imidazo[1,2-a]pyridin-2-ylphenyl]imidazo[1,2-a]pyridin-2-yl]phenyl]-3,4-dimethoxybenzamide
CID 129252689
N-[2-[6-[3-[(2,4-dimethoxybenzoyl)amino]-4-imidazo[1,2-a]pyridin-2-ylphenyl]imidazo[1,2-a]pyridin-2-yl]phenyl]-3,4-dimethoxybenzamide
CID 132078035

Frequently Asked Questions

What is the IUPAC name of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide?
The IUPAC name of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide (CID 159131370) is N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide.
What is the SMILES notation for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide?
The canonical SMILES for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide is COc1cc(OC)cc(C(=O)NCC2CCC(c3nc(-c4cc5ccccc5[nH]4)c4c(N)nccn34)CC2)c1.COc1ccc(C(=O)NCC2CCC(c3nc(-c4cc5ccccc5[nH]4)c4c(N)nccn34)CC2)c(OC)c1.Nc1nccn2c(C3CCC(CNC(=O)C4CC4c4ccccc4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC(CNC=O)CC3)nc(-c3cc4ccccc4[nH]3)c12.
What is the InChIKey of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide?
The InChIKey is KGXZXWGHSFLZIG-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H32N6O.2C30H32N6O3.C22H24N6O/c32-29-28-27(26-16-22-8-4-5-9-25(22)35-26)36-30(37(28)15-14-33-29)21-12-10-19(11-13-21)18-34-31(38)24-17-23(24)20-6-2-1-3-7-20;1-38-22-13-21(14-23(16-22)39-2)30(37)33-17-18-7-9-19(10-8-18)29-35-26(27-28(31)32-11-12-36(27)29)25-15-20-5-3-4-6-24(20)34-25;1-38-21-11-12-22(25(16-21)39-2)30(37)33-17-18-7-9-19(10-8-18)29-35-26(27-28(31)32-13-14-36(27)29)24-15-20-5-3-4-6-23(20)34-24;23-21-20-19(18-11-16-3-1-2-4-17(16)26-18)27-22(28(20)10-9-25-21)15-7-5-14(6-8-15)12-24-13-29/h1-9,14-16,19,21,23-24,35H,10-13,17-18H2,(H2,32,33)(H,34,38);2*3-6,11-16,18-19,34H,7-10,17H2,1-2H3,(H2,31,32)(H,33,37);1-4,9-11,13-15,26H,5-8,12H2,(H2,23,25)(H,24,29).
What are the key properties of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide?
N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide has a molecular weight of 1942.36 g/mol, XLogP of 19.49, 25 rotatable bonds, 12 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2,4-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3,5-dimethoxybenzamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]formamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-phenylcyclopropane-1-carboxamide is sourced from PubChem (CID 159131370), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).